| bioMérieux sa - SWOT Analysis company | | | | of industrial or environmental samples. The |
| profile is the essential source for top-level | | | | company primarily operates in France. It is |
| company data and information. bioMérieux sa - | | | | headquartered in Marcy l'Etoile, France and |
| SWOT Analysis examines the company's key | | | | employed 6,140 people as of December 2008. |
| business structure and operations, history and | | | | The company recorded revenues of E1,110.5 |
| products, and provides summary analysis of its | | | | million (approximately $1,633.9 million) during the |
| key revenue lines and strategy. | | | | financial year (FY) ended December 2008, an |
| BioMerieux is a part of the Merieux Alliance group. | | | | increase of 4.5% over FY2007. The increase was |
| The company is engaged in providing in-vitro | | | | due higher sales of reagents. The operating profit |
| diagnostics for medical and industrial applications. | | | | of the company was E186.1 million (approximately |
| The company designs, develops, manufactures | | | | $273.8 million) during FY2008, an increase of |
| and markets systems used in clinical applications, | | | | 24.1% over FY2007. The net profit was E129.9 |
| such as for the diagnosis of infectious diseases, | | | | million (approximately $191.1 million) in FY2008, an |
| and industrial applications, such as for the analysis | | | | increase of 32.6% over FY2007. |